Precision Medicine Platforms
Part of Healthcare - Genomics & Precision Medicine
 AZN | AstraZeneca PLC | $243.3b | $158.69 | +0.0% | 4.9K |
 TMO | Thermo Fisher Scientific, Inc. | $242.1b | $658.73 | 0.0% | 24 |
 DHR | Danaher Corporation | $150.5b | $217.41 | 0.0% | 11 |
 WAT | Waters Corp | $41.8b | $436.90 | 0.0% | 1 |
 GH | Guardant Health, Inc. Common Stock | $23.9b | $170.00 | 0.0% | 125 |
 RVTY | Revvity, Inc. | $16.9b | $151.34 | 0.0% | N/A |
 TEM | Tempus AI, Inc. Class A Common Stock | $13.9b | $71.50 | 0.0% | 64.8K |
 BBIO | BridgeBio Pharma, Inc. Common Stock | $13.1b | $66.98 | 0.0% | 644 |
 TWST | Twist Bioscience Corporation Common Stock | $12.5b | $163.97 | 0.0% | 19.0K |
 TECH | Bio-Techne Corp. | $11.4b | $70.39 | 0.0% | 5 |
 NUVL | Nuvalent, Inc. Class A Common Stock | $9.8b | $123.96 | 0.0% | N/A |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $8.9b | $106.06 | 0.0% | 12 |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | $8.3b | $277.50 | 0.0% | N/A |
 CAI | Caris Life Sciences, Inc. Common Stock | $8.0b | $27.19 | 0.0% | 7.2K |
 LNTH | Lantheus Holdings, Inc | $6.5b | $100.00 | 0.0% | N/A |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | $4.5b | $26.72 | 0.0% | 54 |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | $3.6b | $36.63 | 0.0% | 20 |
 CDNA | CareDx, Inc. | $3.5b | $63.50 | 0.0% | 345 |
 DYN | Dyne Therapeutics, Inc. Common Stock | $2.8b | $15.60 | 0.0% | 10.8K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | $2.2b | $68.82 | 0.0% | 112 |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.5b | $26.46 | 0.0% | N/A |
 CSTL | Castle Biosciences, Inc. Common Stock | $1.1b | $33.39 | 0.0% | N/A |
 ANRO | Alto Neuroscience Inc. | $1.0b | $23.49 | 0.0% | N/A |
 CTKB | Cytek Biosciences, Inc. Common Stock | $0.8b | $5.42 | 0.0% | 22 |
 NVCT | Nuvectis Pharma, Inc. Common Stock | $0.7b | $19.74 | 0.0% | 5 |
 OABI | OmniAb, Inc. Common Stock | $0.7b | $4.34 | 0.0% | 11 |
 SOPH | SOPHiA GENETICS SA Ordinary Shares | $0.7b | $7.79 | 0.0% | 1.6K |
 AURA | Aura Biosciences, Inc. Common Stock | $0.6b | $6.13 | 0.0% | 17 |
 QSI | Quantum-Si Incorporated Class A Common Stock | $339.3m | $1.20 | 0.0% | 43.9K |
 PRLD | Prelude Therapeutics Incorporated | $292.9m | $3.81 | 0.0% | N/A |
 BDSX | Biodesix, Inc. Common Stock | $292.5m | $28.13 | 0.0% | N/A |
 LAB | Standard BioTools Inc. Common Stock | $292.4m | $0.72 | 0.0% | 9 |
 ACIU | AC Immune SA | $270.9m | $2.51 | 0.0% | N/A |
 NAUT | Nautilus Biotechnolgy, Inc. Common Stock | $249.4m | $1.79 | 0.0% | 57.0K |
 XGN | Exagen Inc. Common Stock | $197.9m | $8.18 | 0.0% | N/A |
 QTRX | Quanterix Corporation Common Stock | $172.1m | $3.44 | 0.0% | 7 |
 AVXL | Anavex Life Sciences | $168.7m | $1.64 | 0.0% | 131 |
 SEER | Seer, Inc. Class A Common Stock | $124.6m | $2.19 | 0.0% | N/A |
 FHTX | Foghorn Therapeutics Inc. Common Stock | $120.0m | $1.90 | 0.0% | 20 |
 ACRV | Acrivon Therapeutics, Inc. Common Stock | $85.3m | $1.86 | 0.0% | N/A |
 SERA | Sera Prognostics, Inc. Class A Common Stock | $82.4m | $2.05 | 0.0% | N/A |
 IBIO | iBio, Inc. Common Stock | $72.3m | $1.05 | 0.0% | 3.2K |
 CSBR | Champions Oncology, Inc. | $68.8m | $5.33 | 0.0% | 6 |
 MDXH | MDxHealth SA Ordinary Shares | $54.5m | $0.60 | 0.0% | 3.5K |
 TVGN | Tevogen Inc. Common Stock | $45.5m | $6.58 | 0.0% | N/A |
 CCEL | Cryo-Cell International Inc. | $32.2m | $4.29 | 0.0% | 4 |
 ALLR | Allarity Therapeutics, Inc. Common Stock | $16.5m | $1.01 | 0.0% | 1 |
 ADVB | Advanced Biomed Inc. Common Stock | $11.1m | $6.94 | 0.0% | 35 |
 CDIO | Cardio Diagnostics Holdings Inc. Common stock | $5.8m | $2.04 | 0.0% | N/A |